Page 380 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 380
SPONSORS’ SYMPOSIA
THURSDAY, APRIL 23, 2015 18:30 – 20:00
Strauss 1 & 2
Janssen Pharmaceutical Companies of Johnson & Johnson
Making the right choice for our hepatitis C patients :
how can we ensure the best outcomes in the real world?
INDUSTRY INFORMATION Chair:
Stefan Zeuzem, Germany
Introduction
Stefan Zeuzem, Germany
Reaching a cure today: the value of triple therapy
Maria Buti, Spain
Using IFN-free regimens in practice: navigating through an ocean of
treatment options
Tarik Asselah, France
From trials to clinical practice: do IFN-free regimens keep their promises?
Fred Poordad, The United States
Panel discussion
Panelists:
Tarik Asselah, France, Maria Buti, Spain, Fred Poordad, The United States,
Stefan Zeuzem, Germany
Closing remarks
Stefan Zeuzem, Germany
380 The International Liver Congress™ 2015 • ILC Programme
THURSDAY, APRIL 23, 2015 18:30 – 20:00
Strauss 1 & 2
Janssen Pharmaceutical Companies of Johnson & Johnson
Making the right choice for our hepatitis C patients :
how can we ensure the best outcomes in the real world?
INDUSTRY INFORMATION Chair:
Stefan Zeuzem, Germany
Introduction
Stefan Zeuzem, Germany
Reaching a cure today: the value of triple therapy
Maria Buti, Spain
Using IFN-free regimens in practice: navigating through an ocean of
treatment options
Tarik Asselah, France
From trials to clinical practice: do IFN-free regimens keep their promises?
Fred Poordad, The United States
Panel discussion
Panelists:
Tarik Asselah, France, Maria Buti, Spain, Fred Poordad, The United States,
Stefan Zeuzem, Germany
Closing remarks
Stefan Zeuzem, Germany
380 The International Liver Congress™ 2015 • ILC Programme
